Proteomics

Dataset Information

0

MiRNA-mediated regulation of hBC cell proteome


ABSTRACT: Estrogen Receptor B (ERB) is a member of the nuclear receptor family of homeostatic regulators that is frequently lost in breast cancer (BC), where its presence correlates with a better prognosis and a less aggressive clinical outcome of the disease. Contrary to ERα, its closest homolog, ERB shows also significant estrogen-independent activities, including the ability to inhibit cell cycle progression and to regulate gene transcription in the absence of the ligand. Investigating the nature and extent of this constitutive activity of ERB in BC MCF-7 cells by miRNA-Seq, we identified 127 miRNAs differentially expressed in ERB+ vs ERB- cells in the absence of ligand, including upregulated oncosuppressor miRs, such miR-30a, and downregulated onco-miRs, like miR-21. In addition, a significant fraction of >1,600 unique proteins identified in these cells by iTRAQ (isobaric Tag for Relative and Absolute Quantitation) quantitative proteomics was either increased or decreased by ERB, revealing regulation of multiple cell pathways by ligand-free receptor. Transcriptome analysis indicates that for a large number of proteins regulated by ERB the corresponding mRNAs are unaffected, including a large number of putative targets of ERB-regulated miRNAs, indicating a central role of miRNAs in mediating BC cell proteome regulation by ERB. Expression of a mimic of miR-30a-5p, a direct target and downstream effector of ERB in BC, led to the identification of several target transcripts of this miRNA, including 11 encoding proteins whose intracellular concentration is significantly affected by unliganded receptor. These results demonstrate a significant effect of ligand-free ERB on BC cell functions via modulation of the cell proteome and suggest that miRNA regulation may represent a key event in the control of the biological and clinical phenotype of hormone-responsive BC by this nuclear receptor.

INSTRUMENT(S): QSTAR

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Tuula Nyman  

PROVIDER: PXD000499 | Pride | 2014-10-23

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
110701GiovannicytoiTRAQB10.wiff Wiff
110701GiovannicytoiTRAQB10.wiff.scan Wiff
110701GiovannicytoiTRAQB11.wiff Wiff
110701GiovannicytoiTRAQB11.wiff.scan Wiff
110701GiovannicytoiTRAQB12.wiff Wiff
Items per page:
1 - 5 of 106
altmetric image

Publications

Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs.

Nassa Giovanni G   Tarallo Roberta R   Giurato Giorgio G   De Filippo Maria Rosaria MR   Ravo Maria M   Rizzo Francesca F   Stellato Claudia C   Ambrosino Concetta C   Baumann Marc M   Lietzèn Niina N   Nyman Tuula A TA   Weisz Alessandro A  

Molecular & cellular proteomics : MCP 20140213 4


Estrogen receptor β (ERβ) is a member of the nuclear receptor family of homeostatic regulators that is frequently lost in breast cancer (BC), where its presence correlates with a better prognosis and a less aggressive clinical outcome of the disease. In contrast to ERα, its closest homolog, ERβ shows significant estrogen-independent activities, including the ability to inhibit cell cycle progression and regulate gene transcription in the absence of the ligand. Investigating the nature and extent  ...[more]

Similar Datasets

2018-08-13 | GSE116881 | GEO
2009-08-18 | GSE14847 | GEO
2010-04-09 | E-GEOD-14847 | biostudies-arrayexpress
2023-08-02 | GSE225327 | GEO
2023-08-02 | GSE225292 | GEO
2011-07-01 | E-GEOD-28321 | biostudies-arrayexpress
2018-03-09 | PXD006059 | JPOST Repository
2010-06-25 | E-GEOD-14685 | biostudies-arrayexpress
2009-05-01 | GSE14685 | GEO
2019-10-14 | PXD015278 | Pride